129579-74-4

Basic information

• Product Name: N-(5-Bromo-[1,3,4]thiadiazol-2-yl)-succinamic acid (3S,8S,9S,10R,13R,14S,17R)-17-((1R,4R)-4-ethyl-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
• Synonyms: N-(5-Bromo-[1,3,4]thiadiazol-2-yl)-succinamic acid (3S,8S,9S,10R,13R,14S,17R)-17-((1R,4R)-4-ethyl-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
• CAS NO: 129579-74-4
• Molecular Weight: 676.802
• Mol File: 129579-74-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(5-Bromo-[1,3,4]thiadiazol-2-yl)-succinamic acid (3S,8S,9S,10R,13R,14S,17R)-17-((1R,4R)-4-ethyl-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-(5-Bromo-[1,3,4]thiadiazol-2-yl)-succinamic acid (3S,8S,9S,10R,13R,14S,17R)-17-((1R,4R)-4-ethyl-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester(129579-74-4)
• EPA Substance Registry System: N-(5-Bromo-[1,3,4]thiadiazol-2-yl)-succinamic acid (3S,8S,9S,10R,13R,14S,17R)-17-((1R,4R)-4-ethyl-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester(129579-74-4)

Safety Data

• Hazardous Substances Data: 129579-74-4(Hazardous Substances Data)

Upstream product

• 81125-68-0 β-Sitosterol-3-hemisuccinate ester chloride 
• 37566-39-5 5-bromo-2-amino-1,3,4-thiadiazole 

Relevant articles and documents

Antilipidemic agents, III: Synthesis of some heterocyclic derivatives of beta-sitosterol.

Four novel series of heterocyclic derivatives of beta-sitosterol were prepared by the reaction of 3-beta-sitosterol hemisuccinate with SOCl2 then with thiols, amines or phenols. These series are: 3 beta-[(3-substituted-4(3H)-quinazolinon-2- yl)thiocarbonylproprionyloxy]stigmast-5-ene; 3 beta- ([4-substituted-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl] thiocarbonylpropionyloxy)stigmast-5-ene; 3 beta- [(5-substituted-1,3,4-thiadiazol-2-yl)carbamoylpropionyloxy] stigmast-5-ene and 3 beta-(substituted carbamoyl or oxycarbonylpropionyloxy)stigmast-5-ene. The antilipidemic activity of representative compounds was studied.